The report also revealed that 87% of physicians agreed that FEE recommendations would help to improve the speed of recovery
Acquisition to advance company's next generation biology portfolio with internationally recognized pioneer in organoid development
Demonstrates vision gains with extended treatment intervals in retinal vein occlusion
An investigational long-acting monoclonal antibody designed to protect infants from RSV disease during their first RSV season
Dr. Berger is a board-certified internist, hematologist and oncologist who brings more than 25 years of extensive experience in developing and delivering innovative medicines
The trademark rights for these brands will be transferred to Lupin by March next year.
GSK secures option to multiple high-value, validated Alzheimer’s-relevant targets for drug discovery, development, and commercialization
The new facility marks a significant milestone for Fredun Pharmaceuticals as it expands its footprint in the rapidly growing pet care industry in India
Attruby is the first and only approved product with a label specifying near-complete stabilization of TTR
First GMP batch released at Lonza’s next-generation mammalian manufacturing facility in Portsmouth (US)
Subscribe To Our Newsletter & Stay Updated
